NEWS
LLNL, DOD, NNSA dedicate Rapid Response Laboratory and supercomputing system to accelerate biodefense
The collaboration has enabled expanding systems of the same architecture as LLNL’s upcoming exascale supercomputer, El Capitan, featuring AMD’s cutting-edge MI300A processors.
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
In a milestone for supercomputing-aided drug design, LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer.
Video: How will El Capitan run?
Discover how the software architecture and storage systems that will drive El Capitan’s performance will help LLNL and the NNSA Tri-Labs push the boundaries of computational science.